NH
Nicholas Holowko UBS Latest Price Targets & Analyst Ratings
Main Sector
Financials
Ratings Past Year
17
Avg Return
Past Year
Past Year
5.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
40%
Neutral
60%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Financials
Healthcare
Financials
Banks - Regional
Credit Services
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $56 |
28%
upside
| 1 | -6.3% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Initiated
| $92 |
25%
upside
| 1 | -7.8% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Initiated
| $15 |
27%
upside
| 1 | -0.76% |
0
%
| 15 Dec ‘25 1 month ago |
|
|
|
Neutral
Initiated
| $25 |
7%
upside
| 1 | – |
–
| 15 Dec ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $34 |
8%
downside
| 1 | – |
–
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $2,250 |
4%
upside
| 1 | +20% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $11.50 |
11%
downside
| 1 | – |
–
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $105 |
19%
upside
| 1 | +14% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $49 | – | 1 | -5.7% |
–
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $95 |
3%
downside
| 1 | – |
–
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $120 |
22%
upside
| 1 | +12% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $57 |
4%
downside
| 1 | – |
–
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $115 |
0%
downside
| 1 | – |
–
| 28 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $50 |
3%
upside
| 1 | – |
–
| 28 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $127 |
1%
downside
| 1 | – |
–
| 24 Oct ‘25 2 months ago |
|